علاج ADPKD مع ارتفاع ضغط الدم لدى الأطفال والمراهقين

References

DOI: 10.1016/j.kint.2024.07.010

We recommend use of RASi (i.e., ACEi or ARBs) as the first-line pharmacologic therapy for high BP in children and adolescents with ADPKD (1D).

We recommend targeting BP to ≤50th percentile for age, sex, and height or ≤110/70 mm Hg in adolescents in the setting of ADPKD and high BP (1D).